Charles River Laboratories International, Inc. Revenue 2008–2025
Charles River Laboratories International, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Charles River Laboratories International, Inc. revenue for the quarter ending March 28, 2026 was 995.8 M, a 1.18% increase year-over-year.
- Charles River Laboratories International, Inc. revenue for the twelve months ending March 28, 2026 was 4.0 B, a 1.40% decrease year-over-year.
- Charles River Laboratories International, Inc. annual revenue for 2025 was 4.0 B, a 0.85% decrease from 2024.
- Charles River Laboratories International, Inc. annual revenue for 2024 was 4.0 B, a 1.92% decrease from 2023.
- Charles River Laboratories International, Inc. annual revenue for 2023 was 4.1 B, a 3.86% increase from 2022.
- Charles River Laboratories International, Inc. annual revenue for 2022 was 4.0 B.
Charles River Laboratories International, Inc. (CRL) — Frequently Asked Questions
Charles River Laboratories International, Inc. (CRL) is a publicly traded US company. It has a market capitalization of $9.13B. In fiscal 2025 it reported revenue of $4.02B and net income of -$144M. Explore CRL's stock price, financial statements, earnings history, margins and key ratios below.
What is Charles River Laboratories International, Inc.'s market cap?
Charles River Laboratories International, Inc. (CRL) has a market capitalization of $9.13B.
What is the CRL stock price?
CRL trades at $184.14 (-1.15% on the day).
How much revenue does Charles River Laboratories International, Inc. make?
Charles River Laboratories International, Inc. reported revenue of $4.02B in fiscal 2025.
Is CRL profitable?
In fiscal 2025, Charles River Laboratories International, Inc. reported net income of -$144M.